Everest Group: Shedding $5B of contested retail premium to buy back into a cleaner, higher-margin reinsurer at 10x earnings

Stevie AI on Everest Group, Ltd. (EG-USA | everestgroup)

4/24/2026

Summary

Everest Group is a global reinsurance and specialty insurance underwriter in the middle of a deliberate business model compression — voluntarily surrendering $5B of gross written premium from its commercial retail insurance book (divested to AIG in October 2025) in exchange for a structurally cleaner expense base, a mid-90s combined ratio, and significantly higher returns on equity. The market is pricing Everest as a revenue-shrinking insurer at roughly 11x current earnings; the correct frame is a focused reinsurer with a $41-44B investment portfolio reinvesting at 4.7-5.0% book yields, a January 2026 renewal book of $6.3B demonstrating preferred market positioning despite 10% rate softening, and a capital return programme that will accelerate materially in 2H 2026 as AIG renewal rights proceeds are released. The divestiture is not a retreat — it is an intentional exit from commodity distribution into expertise-driven underwriting where Everest has genuine pricing authority. Recent financial performance reflects the transitional nature of 2024-2025. FY2024 actuals show revenue of $1.5B and net income of $1.4B at $31.78 EPS — numbers that appear anomalous against the $15.8B net premiums written figure because of how premium flows are reported versus earned income. The reinsurance segment delivered Q4 2025 underwriting income of $255M, and the January 1, 2026 renewal cycle produced $6.3B in signings while retaining 95% of top-tier accounts despite a softer rate environment, validating the thesis that Everest's underwriting relationships are durable rather than price-dependent. The near-term EPS dip to $18.68 in FY2025 reflects divestiture transition costs and elevated loss picks in U.S. casualty — this is the trough, not the trend. We apply a 13x P/E multiple to forward earnings, reflecting Everest's post-divestiture profile as a reinsurance-dominant underwriter with improving combined ratios, a large high-quality investment portfolio, and an active buyback programme compressing the share count from ~74M toward ~70M by 2028. This multiple is a modest premium to the large-cap reinsurance peer group (Munich Re, Hannover Re trade at 11-13x) and a discount to specialty insurers with comparable margin trajectories, justified by the execution risk embedded in the retail runoff period. At $18.68 FY2025 EPS the stock screens cheap on a trough basis; the more instructive anchor is FY2027 EPS of $31.10, which at 13x yields a price target of $404 — 15% above current levels — with FY2028 at $35.02 implying $455, or 30% upside over a two-year hold. The buyback programme provides a floor: $400-600M annually at current prices retires roughly 1.5-2% of the float per year, with acceleration expected post-capital release in 2H 2026.

Thesis

1. **The AIG Divestiture Is a Margin Event, Not a Revenue Retreat** Everest's decision to divest its commercial retail insurance book to AIG removes approximately $5B of gross premiums written that were structurally dilutive to underwriting margins. Retail commercial insurance in the U.S. is a distribution-heavy, expense-intensive business where Everest lacked the scale or proprietary distribution of tier-one carriers. The combined ratio drag from this segment was measurable: group expense ratios ran in the high-20% range through 2024-2025, a significant spread above management's 6-7% target on a reinsurance-dominant basis. Post-divestiture, the expense ratio is expected to compress toward 6% by year-end 2026 as retail overhead — which ran in the low $400M range in 2025 — falls to an estimated $50M residual by year-end. This is not financial engineering; it is the removal of a structurally inferior cost base. The combined ratio improvement of 3-4 percentage points translates directly into underwriting income, and on a $15-18B net premium base the dollar impact is $450-720M annually. This is the core earnings inflection the market has not yet priced. The insurance segment that remains — Global Wholesale and Specialty — is categorically different from what was sold. Facultative reinsurance (~$1.2B), Lloyd's Syndicate 2786, the U.S. E&S Evolution platform, and specialty marine and energy lines are expertise-gated businesses with higher technical barriers and more defensible pricing. The mid-90s all-in combined ratio target for this segment in 2026 is achievable and, importantly, structurally sustainable in a way that retail commercial was not. 2. **January 2026 Renewals Demonstrate Pricing Power in a Softening Market** The January 1, 2026 renewal cycle is the most important near-term datapoint for evaluating Everest's competitive position. Despite a 10% rate decline across property catastrophe reinsurance — driven by two years of strong industry profitability and new capital inflows — Everest held GWP declines to only 1% and retained 95% of its top-tier accounts. This is a materially better outcome than rate movement alone would imply and reflects genuine preferred cedent relationships rather than price competition. The $6.3B in renewal signings represents a stable, recurring premium base anchored in relationships built over multiple loss cycles. Reinsurance is a trust business: cedents allocate capacity to counterparties they believe will pay claims promptly and maintain long-term panel presence. Everest's willingness to stay on panels through difficult casualty years — rather than cutting and running — has compounded into structural access that newer or more opportunistic capital cannot easily replicate. The 10% rate softening is a legitimate headwind but should be contextualised. Property catastrophe rates remain well above pre-2017 levels on a risk-adjusted basis, and the reinsurance industry's aggregate combined ratio was profitable in 2024-2025 even at current rates. Everest's January renewals demonstrate that it can navigate a moderating rate environment without ceding market share, which is the key test of underwriting franchise quality. If catastrophe loss activity normalises in 2026-2027, the combined ratio benefits from favourable loss experience on top of the expense ratio improvement. 3. **Investment Portfolio Yield Expansion Is a Structural Tailwind Hiding in Plain Sight** Everest manages a $41-44B investment portfolio, predominantly fixed income, with an average book yield reinvesting at approximately 4.7-5.0%. This is the post-zero-rate era benefit that accrues to long-duration insurers with high-quality bond portfolios: as legacy low-yield paper matures and is reinvested at current rates, net investment income grows without any underwriting action required. The magnitude of this tailwind is underappreciated in the consensus. A $42B portfolio moving from an average book yield of, say, 3.5% to 4.8% over a 4-5 year reinvestment cycle adds approximately $540M in annual pre-tax investment income at full run-rate — a number that is material relative to FY2025 net income of $1.4B. Management has an additional duration extension opportunity: if rates remain elevated, extending fixed income duration locks in current yields and further de-risks the investment income trajectory. Net investment income growth is a key driver of the EPS ramp from $18.68 in 2025 to $35.02 in 2028. This is not contingent on underwriting outperformance or favourable catastrophe experience — it is the mechanical consequence of portfolio size and reinvestment arithmetic. In a scenario where underwriting results disappoint modestly, investment income provides meaningful earnings support, which is a risk-mitigation property the market does not appear to be pricing into the valuation. 4. **Buyback Programme Compresses the Share Count at a Trough Valuation** Everest's $400-600M annual buyback programme is being executed at approximately 10-11x trough earnings, which is accretive capital allocation by any reasonable standard. At $350 per share, $500M of annual repurchases retires approximately 1.43M shares — roughly 2% of the diluted count — per year. Management's guidance of share count compression from ~74M toward ~70M by 2028 implies cumulative retirements of approximately 5-6% of the float over the forecast period. The more significant catalyst is the capital release expected in 2H 2026 from the AIG renewal rights transaction maturation. Management has explicitly guided to 'significant levels of net income' generation and 'expected capital releases in the back half of the year.' If this release is realised as anticipated — and the mechanics of renewal rights transactions suggest it is largely formulaic — the buyback pace could accelerate meaningfully in late 2026 and into 2027, pulling forward the EPS accretion from share count reduction. At $27.64 FY2026 EPS and a 13x multiple, the stock should be trading at $359 — essentially flat to current price — meaning investors are being compensated with buyback accretion and investment income growth for waiting through the divestiture transition year. The asymmetry improves substantially into 2027-2028 as the cleaner business model is fully reflected in reported numbers. 5. **Reserving Conservatism Partially Insulates Against the U.S. Casualty Cycle** U.S. social inflation and casualty reserve adequacy is the industry-wide concern that most weighs on reinsurer valuations. Everest has taken a more proactive posture than peers in several respects: the company entered into an Adverse Development Cover (ADC) to cap prior-year casualty reserve development, elevated 2026 loss picks above trend to embed conservatism in current-year underwriting, and management explicitly acknowledged the U.S. legal environment as an ongoing challenge rather than dismissing it. The ADC structure is material. By ceding adverse development above a defined threshold to a third-party reinsurer, Everest has effectively purchased a put option on its casualty reserve adequacy. The cost of this cover is embedded in FY2025-2026 loss ratios, which partially explains the near-term EPS compression. But the benefit — protection against a tail scenario of sustained reserve deterioration — is not fully reflected in the market's risk premium applied to the stock. The $1B+ supporting reserves held in the Other segment provide an additional buffer. While the composition and release timing of this reserve are uncertain, it represents balance sheet optionality that is not in consensus EPS estimates. Any favourable development from this position in 2026-2027 would be additive to the base case earnings trajectory and could represent a positive catalyst if reserve releases materialise. 6. **Valuation Is Compelling on a Through-the-Cycle Basis** At $350.81, Everest trades at 18.8x FY2025 trough EPS of $18.68 — which looks expensive in isolation but is misleading given the one-time divestiture drag. On FY2026 EPS of $27.64, the stock trades at 12.7x, and on FY2027 EPS of $31.10, it trades at 11.3x. These multiples sit at or below the peer group for large-cap global reinsurers (Munich Re: 12-13x, Hannover Re: 11-12x) despite Everest's structurally improving margin profile and active capital return programme. The FCF trajectory reinforces the valuation case: $2.0B in FY2025 growing to $3.0B by FY2028 on a market cap of approximately $26B implies a 2028 FCF yield of roughly 11.5%. This is a level typically associated with value traps or structurally declining businesses — not with a reinsurer growing net income at a 15%+ CAGR from trough and actively buying back stock. The market appears to be applying a haircut for execution risk on the divestiture transition and for U.S. casualty uncertainty that is not commensurate with the mitigants Everest has put in place.

Risks

1. **Social Inflation and U.S. Casualty Reserve Deterioration** Management's own language — 'ongoing challenges posed by the abuse of the U.S. legal system' — signals that casualty reserve adequacy remains an open question despite the ADC cover and elevated loss picks. If U.S. third-party litigation funding and nuclear verdict frequency continue to accelerate beyond current assumptions, Everest could face reserve additions that overwhelm the ADC buffer and require earnings charges in 2026-2027. This is the single most material downside risk and the primary reason the stock trades at a discount to its intrinsic value. A 2-3 point combined ratio deterioration from unexpected casualty development would reduce FY2026 net income by approximately $300-450M and could force a reassessment of the capital return programme. 2. **AIG Divestiture Execution and Transition Risk** The retail divestiture is structurally complex: renewal rights transactions involve the gradual transfer of customer relationships over 12-18 months, with residual overhead costs persisting well into the transition period. Management's estimate of ~$50M residual overhead by year-end 2026 (versus low $400M in 2025) requires successful staff reductions, systems separation, and AIG's active management of the renewal process. If the transition is slower than guided — either because AIG encounters distribution challenges or because Everest retains more infrastructure than planned — the expense ratio improvement will lag, compressing the 2026 earnings recovery thesis. 3. **Property Catastrophe Rate Softening Accelerates Beyond Current Trajectory** The 10% rate decline at January 1, 2026 renewals was manageable, and Everest absorbed it without meaningful volume loss. However, if a second consecutive benign catastrophe year in 2025-2026 drives further new capital inflows and rate reductions of 15-20% at January 2027 renewals, the reinsurance segment combined ratio could deteriorate as premium adequacy erodes. Everest's property cat book represents a meaningful portion of reinsurance segment income, and a sustained multi-year soft market would compress margins even on a disciplined underwriting posture. The 1-in-100 year scenario is a $1B+ underwriting loss combined with soft rates, limiting the company's ability to reprice. 4. **Investment Portfolio Duration and Credit Risk** The $41-44B investment portfolio is a source of earnings stability in the base case, but it carries duration risk if interest rates decline materially from current levels. The forecast assumes reinvestment at 4.7-5.0% book yields; a 100bps decline in rates reduces the annual investment income run-rate by approximately $420-440M at full portfolio scale, meaningfully compressing net income. Additionally, while the portfolio is described as high-quality fixed income, concentration in any credit sector (structured finance, corporate credit) exposed to an economic downturn would introduce mark-to-market losses and potential realised losses that flow through the income statement. 5. **Capital Release Timing Risk on AIG Transaction** Management has guided to 'expected capital releases in the back half of 2026' from the AIG renewal rights transaction. This expectation underpins the acceleration in the buyback programme and the FY2026-2027 EPS trajectory. If the capital release is delayed — due to regulatory approval timelines, dispute over renewal rights valuations, or slower-than-expected premium migration to AIG — the buyback acceleration thesis is pushed out by 12-18 months, reducing the near-term EPS accretion from share count compression. The magnitude of the release is also not precisely quantified, creating forecast uncertainty around the FY2026 capital return assumption. 6. **Global Wholesale and Specialty Segment Margin Stabilisation** The remaining insurance segment — repositioned as Global Wholesale and Specialty — is in transition. Q4 2025 results were elevated by energy losses and ADC premium costs, and management's mid-90s combined ratio target for 2026 assumes these are non-recurring. However, the Lloyd's Syndicate 2786, E&S Evolution platform, and specialty marine and energy lines are all exposed to large single-risk losses (as evidenced by the Q4 2025 energy event). If the specialty book produces two or more outsized loss events in 2026 before the expense ratio improvement is fully realised, the all-in combined ratio could remain above mid-90s, delaying the segment's contribution to group profitability and testing management's credibility on the transition narrative.

📈 Price Targets